Search clinical trials for: PF-03882845 or Placebo

Total 1154 results

University of Chicago
Genentech, Inc.; Novartis Pharmaceuticals

Completed

Xolair in Patients With Chronic Sinusitis

Sinusitis

United States
Société des Produits Nestlé (SPN)

Completed

Children Immune Functions

Diarrhea | Upper Respiratory Infections

Mexico
NAOS Institute of Life Science

Not yet recruiting

MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis

Actinic Keratosis | Actinic Lentigo
Pfizer

Completed

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

COVID-19

United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
Aker Biomarine Antarctic AS

Completed

KOmparison Study KOmparison Study

Healthy

Germany
Amgen

Withdrawn

Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma

Asthma
Centocor, Inc.

Completed

A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

Healthy Volunteers

United States
Pfizer

Recruiting

A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Influenza | Vaccines | Grippe

United States
Pfizer

Terminated

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Plaque Psoriasis

United States, Canada
Uppsala University Hospital
Swedish Cancer Society; Lantmännen AB; Sjöbergstiftelsen; Onkologiska klinikens...

Not yet recruiting

Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma (SALFLAC)

Anal Cancer
Uppsala University Hospital
Swedish Cancer Society; Lantmännen AB; Sjöbergstiftelsen; Onkologiska klinikens...

Recruiting

Role of Antisecretory Factor in Dihydropyrimidine Treatment of Colorectal Cancer (SALFLADMET)

Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer

Sweden
PiLeJe
Clinact; Clinfile

Terminated

Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children (EPISODE)

Nosocomial Infection | Diarrhea, Infantile

France
Italfarmaco S.A

Completed

Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

Vaginal Atrophy

Spain
University of Zurich

Completed

Dietary Fibers and Satiety in Bariatric Patients (FIBAR)

Bariatric Surgery Candidate

Switzerland
East Tennessee State University
Takeda Pharmaceuticals North America, Inc.

Completed

The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

Diabetes Type 2

United States
Pfizer

Completed

A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain

Osteoarthritis

United States
Cancer Institute and Hospital, Chinese Academy...
The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... and other collaborators

Recruiting

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Esophageal Neoplasms

China
Suzhou Transcenta Therapeutics Co., Ltd.

Not yet recruiting

Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

Gastric Cancer | Advanced Cancer | Gastroesophageal-junction Cancer
Al-Azhar University

Unknown

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Skin Diseases | Breast Cancer | Skin Cancer

Egypt, Saudi Arabia
US Department of Veterans Affairs
Ortho Dermatologics

Completed

Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer

Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Skin Neoplasms

United States
Idorsia Pharmaceuticals Ltd.

Terminated

A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478

Healthy

Germany
Nobelpharma

Completed

Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)

Qt Interval, Variation in

Japan
Pfizer

Completed

An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis

Cystitis, Interstitial

United States
Probi AB

Completed

Study of the Iron Absorption From Capsules Containing Lactobacilli and Iron

Healthy

Sweden
Kronos Longevity Research Institute
Mayo Clinic; Albert Einstein College of Medicine; Yale University; Columbia University and other collaborators

Unknown

Kronos Early Estrogen Prevention Study (KEEPS)

Arteriosclerosis | Menopause

United States
Washington University School of Medicine
COVID -19 Therapeutics Accelerator

Completed

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION (CROWN CORONA)

COVID 19

United States, South Africa, Ghana, United Kingdom, Zambia
Ahon Pharmaceutical Co., Ltd.

Completed

Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Advanced Breast Cancer

China
Alios Biopharma Inc.

Completed

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, Moldova, Republic of, New Zealand, Thailand, Ukraine
Women and Infants Hospital of Rhode Island
National Institute of General Medical Sciences (NIGMS)

Withdrawn

Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

Neonatal Opioid Withdrawal Syndrome

United States
Pfizer

Completed

ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer (ARCHER 1009)

Non-Small Cell Lung Cancer

United States, Korea, Republic of, United Kingdom, Greece, Slovakia, France, Belgium, Ireland, Japan, Spain, China, Sweden, India, Hungary, Switzerland, Russian Federation, Germany, Mexico, Denmark, Austria, Finland, Poland, South Africa
Pfizer

Terminated

A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

Healthy

Singapore
University of California, Los Angeles

Not yet recruiting

Cannabidiol for Reducing Cigarette Use

Tobacco Smoking | Tobacco Use Disorder | Tobacco Dependence

United States
Abbott

Completed

An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

Hypertriglyceridemia
Antonio Di Sabatino

Unknown

Dose-finding Gluten Challenge Trial in Nonceliac Gluten-sensitivity (RAPLAGE)

Nonceliac Gluten Sensitivity

Italy
ConjuChem

Completed

A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy

Type 2 Diabetes Mellitus

Canada
Pfizer

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects

Healthy Volunteers

United States
Pfizer

Terminated

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-2)

Cardiovascular Disease

United States, Finland, Netherlands, Spain, Belgium, Germany, Czechia, Switzerland, Denmark, Australia, United Kingdom, Korea, Republic of, Hungary, Israel, Poland, Taiwan, Mexico, Turkey, Ireland, Canada, New Zealand, South Africa, Brazi... and more
Pfizer

Completed

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events (SPIRE-LDL)

Hyperlipidemia

United States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
Pfizer

Completed

A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia (SPIRE-FH)

Heterozygous Familial Hypercholesterolemia

Canada, Netherlands, United Kingdom, United States, Spain, Poland, Finland, Norway, South Africa, Italy, Bulgaria
Pfizer

Terminated

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

Brazil, Germany, Korea, Republic of, Belgium, Spain, Slovakia, France
AdvanceCor GmbH

Completed

Revacept in Symptomatic Carotid Stenosis (RevaceptCS02)

Stroke | Atherosclerosis | Carotid Stenosis | TIA | Transient-ischaemic Attack | Amaurosis Fugax

Germany, United Kingdom
Johns Hopkins University

Completed

The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol

Cannabidiol Pharmacokinetics

United States
Xijing Hospital of Digestive Diseases

Unknown

Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure

Acute-On-Chronic Liver Failure

China
Klara Posfay-Barbe
Gertrude Von Meissner Foundation; Recherche et Développement des HUG; Société...

Unknown

Group A Pharyngitis in Children: The GASPARD Study (GASPARD)

Group A Streptococcal Pharyngitis

Switzerland
Centocor, Inc.

Completed

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Crohn Disease
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

Crohn Disease
Pfizer

Completed

A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects

Healthy Volunteers

Belgium
Read-Gene S.A.
National Center for Research and Development, Poland; IQ Pharma S.A.; West Pomeranian... and other collaborators

Active, not recruiting

Prevention of Female Cancers by Optimization of Selenium Levels in the Organism. (SELINA)

Breast Neoplasms

Poland
Massachusetts General Hospital
Pfizer

Active, not recruiting

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Pain | Schwannomatosis

United States
Boehringer Ingelheim

Completed

Rt-PA in the Treatment of Acute Ischemic Stroke

Cerebrovascular Accident

Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, Switzerland, United Kingdom

Search clinical trials for: PF-03882845 or Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations